Publication | Closed Access

Co-delivery of LOX-1 siRNA and statin to endothelial cells and macrophages in the atherosclerotic lesions by a dual-targeting core-shell nanoplatform: A dual cell therapy to regress plaques

NanomedicineDrug TargetingEngineeringTherapeutic NanomaterialsLox-1 SirnaVascular BiologyNano-drug DeliveryBiomedical EngineeringDual Cell TherapyMedicineCell BiologyAtherosclerosisDual-targeting Core-shell Nanoplatform